Simplex Trading’s Tenaya Therapeutics TNYA Stock Holding History

Simplex Trading’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$207	Sell	300 -11,900	-98%	-$8.78K	﹤0.01%	8834
2025 Q4	$8.69K	Sell	12,200 -3,100	-20%	-$4.22K	﹤0.01%	7074
2025 Q3	$24K	Sell	15,300 -5,900	-28%	-$5.94K	﹤0.01%	7193
2025 Q2	$12K	Buy	+21,200	New	+$10.8K	﹤0.01%	7204
2025 Q1	–	Sell	-16,700	Closed	-$23K	–	9691
2024 Q4	$23K	Buy	+16,700	New	+$37.4K	﹤0.01%	6588
2023 Q4	–	Sell	-500	Closed	-$1K	–	9836
2023 Q3	$1K	Hold	500	–	–	﹤0.01%	8430
2023 Q2	$2K	Sell	500 -39,900	-99%	-$232K	﹤0.01%	8488
2023 Q1	$115K	Buy	40,400 +38,600	+2,144%	+$108K	﹤0.01%	5003
2022 Q4	$3K	Sell	1,800 -1,200	-40%	-$2.93K	﹤0.01%	8434
2022 Q3	$8K	Buy	+3,000	New	+$14K	﹤0.01%	8446

Other funds holding TNYA

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BGM

Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $141M AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simplex Trading's TNYA Position: Q1 2026 in Review

Simplex Trading increased its Tenaya Therapeutics (TNYA) stake by 31% in Q1 2026, buying an estimated $8.94K and bringing the position to 50,655 shares worth $35.1K. The position accounts for ﹤0.01% of the portfolio, ranked #6230.

Simplex Trading first reported a position in TNYA in Q3 2022 and has held it in 13 quarters since. The position peaked at $181K in Q3 2025. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

Simplex Trading held 50,655 shares of Tenaya Therapeutics worth $35.1K as of Q1 2026.
Simplex Trading bought 12,112 Tenaya Therapeutics shares in Q1 2026, an estimated $8.94K.
Tenaya Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6230 holding.
Simplex Trading first reported a position in Tenaya Therapeutics in Q3 2022 and has held it in 13 quarters since.
Simplex Trading's Tenaya Therapeutics position peaked at $181K in Q3 2025.
103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.